Medscape1d
Underfunded, Underdiagnosed, and Misunderstood: What’s Next for Bipolar Disorder
BD affects millions but remains misunderstood, underdiagnosed, and underfunded. Researchers are working to change this by ...
Healio4d
Researchers stress need for clear, consistent standards in FDA review of psychiatric drugs
The FDA approved 16 psychiatric drugs over the last decade, most of which shared similar mechanisms of action with previously ...
pharmaphorum6d
FDA clears Rexulti as first drug for Alzheimer’s agitation
Rexulti (brexpiprazole) is already one of the two drugmakers’ fastest-growing products, and analysts have suggested that the new use could swell sales by $500 million to $1 billion, which would ...
money.rediff5d
Alembic Ltd.
Alembic Pharmaceuticals has received USFDA approval for its generic version of Brexpiprazole tablets, used to treat major depressive disorder. The approval covers strengths ranging from 0.25 mg to ...
Business Standard1d
Alembic Pharmaceuticals Share Price
Alembic Pharmaceuticals manufactures and markets generic pharmaceutical products all over the world. The company's state of the art research and manufacturing facilities are approved by regulatory ...